TP53 and hepatocellular carcinoma: Accordingly, treatment of the DNA-damaging agent daunorubicin led to increased PVT1 transcripts and to significantly increased miR-1206 expression in hepatocellular carcinoma SK-HEP1 cells, colon carcinoma PKO, and HCT116 cells in a p53-dependent manner [52].